SectorWatch.biz Issues MarketStats on Renal and Medical Device Equities XCR, FMS, MDT, VAR, and NXTM

IRVINE, Calif., July 28  /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats for renal and medical device equities in the news and driving markets today. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles, blogs and opinions.

Investors can view MarketStats by visiting: http://www.sectorwatch.biz/ -- a division of FiSpace.net, a dynamic social networking site for investors.

Today's MarketStats for renal and medical device companies include Xcorporeal, Inc. (AMEX:XCR), Fresenius, Inc. (NYSE:FMS), Medtronic Inc (NYSE:MDT), Varian Medical Systems (NYSE:VAR), and NxStage Medical (NASDAQ:NXTM).

For a corporate profile on Xcorporeal, Inc. (AMEX:XCR) visit the following link: http://www.stockupticks.com/profiles/7-26-08.html

A Roth Capital Partners' May 2008 Research Report on Xcorporeal is available at that page as well.

FiSpace.net is the premiere Internet destination for stock market readers and writers, allowing individuals to post blogs, articles, messages and more in organized sector channels, allowing for the effective exchange of ideas. By posting content on FiSpace.net individuals can acquire F.A.N.S. (Financial Networked Subscribers) who help increase the author's influence and standing on the site in an unprecedented way.

SectorWatch.biz is powered by Market Pathways, a leader in the representation of Small Cap equities for nearly thirty years. Market Pathways' analyst Brian Kelly holds CRD #2880975.

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SectorWatch.biz, FiSpace.net and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report. This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. MP has been paid ten thousand dollars by Atlanta Capital for preparation and distribution of this report and other advertising services over a thirty day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company. 

DATASOURCE: SectorWatch.biz



CONTACT:  Shannon Squyres, Editor of Market Pathways - SectorWatch.biz,

[phone]



Web site:  http://www.marketpathways.com/

http://www.sectorwatch.biz/

http://www.stockupticks.com/profiles/7-26-08.html 

Copyright